Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-978-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
An integrated testing strategy, using a battery of three studies addressing the different key events of skin sensitisation is usesd. The following studeis were conduxcted.
1)In chemico Direct peptite reactivity assay ( DPRA) . result: negative
2) In vitro KeratinoSens. result:negative
3) Cell line activation test for skin sensitization (Usens): result negative.
It was concluded that the test item Reaction mass of disodium 2,2 oxydiethanesulfonate and sodium ethenesulfonate was not considered to be a skin sensitizer
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2021
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442E (In Vitro Skin Sensitisation assays addressing the key event on activation of dendritic cells on the Adverse Outcome Pathway for skin sensitisation)
- GLP compliance:
- yes
- Type of study:
- U937 cell line activation test (U-SENS™)
- Specific details on test material used for the study:
- Reaction mass of disodium 2,2 oxydiethanesulfonate and sodium ethenesulfonate
Batch lot number:202108300033
Dry weight content : 33.65 % - Vehicle / solvent control:
- cell culture medium
- Negative control:
- DL-Lactic acid
- Positive control:
- other: 2,4,6 Trinitrobenzenesulfonic acid
- Group:
- test chemical
- Run / experiment:
- run/experiment 2
- Parameter:
- EC150, CD86 [442E]
- Cell viability:
- The test item showed no cytotoxicity, the viability of the cells was higher than 70% at all test concentrations and therefore no CV70 values could be calculated and is considered to be higher than 200 µg/mL.
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: • No biologically relevant increase in expression levels of CD86 compared to the vehicle control was observed at any of the test concentrations after treatment with the test item. No EC150 could be calculated and is considered to be higher than 200 µg/mL.
- Key result
- Group:
- test chemical
- Run / experiment:
- run/experiment 1
- Parameter:
- EC150, CD86 [442E]
- Cell viability:
- The test item showed no cytotoxicity, the viability of the cells was higher than 70% at all test concentrations and therefore no CV70 values could be calculated and is considered to be higher than 200 µg/mL.
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: No EC150 could be calculated and is considered to be higher than 200 µg/mL.
- Outcome of the prediction model:
- negative [in vitro/in chemico]
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In conclusion, Reaction mass of disodium 2,2’-oxydiethanesulfonate and sodium ethenesulfonate is classified as negative (no biologically relevant increase in the expression levels of CD86 cell surface marker in the U937 cell line) under the experimental conditions described in this report.
- Executive summary:
The objective of this study is to evaluate the ability of the test item to increase the expression levels of CD86 cell surface marker in the U937 cell line activation Test (U-Sens™) assay.
The test item was evaluated for the ability to increase the expression levels of CD86 cell surface marker. An overview of the viability and CD86 cell surface marker activity is summarized in Table 1. The results of the positive, negative and vehicle controls are summarized in Table 2. An overview of EC150 and CV70 values is given in Table 3. The individual raw data are presented in Table 4 and Table 5.
Two independent experiments were performed. The cell viability before incubation with the test item was > 90% (98% and 97% in experiment 1 and 2, respectively). The cells were in these experiments incubated with the test item in a concentration range of 1.0 – 200 µg/mL. The increase of CD86 cell surface marker expression was assessed by measuring the amount fluorescent cell staining of the CD86 cell surface marker compared to the vehicle control. In addition, the viability was assessed with propidium iodide.
Experiment 1
- No precipitation was observed at the end of the incubation period in the 96-well plates.
- The test item showed no toxicity, the viability of the cells was higher than 70% at all test concentrations and therefore no CV70 values could be calculated and is considered to be higher than 200 µg/mL.
- No increase in expression levels of CD86 compared to the vehicle control was observed at any of the test concentrations after treatment with the test item. No EC150 could be calculated and is considered to be higher than 200 µg/mL.
- The test item showed no colour interference.
- The positive control (TNBS) showed a S.I. ≥ 1033% in all wells and was non-cytotoxic at all concentrations (cell viability ≥ 70%). The negative control (LA) showed a I. ≤ 88% in all wells and was non-cytotoxic at all concentrations (cell viability ≥ 70%).
Experiment 2
- No precipitation was observed at the end of the incubation period in the 96-well plates.
- The test item showed no toxicity, the viability of the cells was higher than 70% at all test concentrations and therefore no CV70 values could be calculated and is considered to be higher than 200 µg/mL.
- No biologically relevant increase in expression levels of CD86 compared to the vehicle control was observed at any of the test concentrations after treatment with the test item. No EC150 could be calculated and is considered to be higher than 200 µg/mL. At the dose level of 100µg/mL, the test item showed a CD86 induction of 153%. However, as this is only just above the threshold of 150%, and only occurred at this dose level and not at the highest dose level, this minor increase is not considered to biologically relevant.
- The test item showed no colour interference.
- The positive control (TNBS) showed a S.I. ≥ 634% in all wells and was non-cytotoxic at all concentrations (cell viability ≥ 70%). The negative control (LA) showed a I. ≤ 148% in all wells and was non-cytotoxic at all concentrations (cell viability ≥ 70%).
Both tests passed the acceptance criteria:
- At the end of the incubation treatment period, the mean viability of the triplicate untreated U937 cells was above the threshold of 90% (99% in experiment 1 and 2).
- The CD86 basal expression of untreated U937 cells is within the range of ≥ 2% and
≤ 25% in both experiments. - At least two out of three IgG1 values of untreated U937 cells fell within the range of
≥ 0.6% and < 1.5% in both experiments. - No drift in CD86 expression was observed in the untreated controls (RPMI) and negative (LA) controls.
In both experiments the positive and negative control were considered valid, and the positive control fell within the historical control data. Overall, it is concluded that the test conditions were adequate and that the test system functioned properly.
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2021
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- GLP compliance:
- yes
- Type of study:
- amino acid derivative reactivity assay (ADRA)
- Specific details on test material used for the study:
- Reaction mass of disodium 2,2 oxydiethanesulfonate and sodium ethenesulfonate
Batch lot number:202108300033
Dry weight content : 33.65 %, correction factor is 2.971. The test item is a multi-constituent
Composition.
Constituent1:Sodium ethylene sulphonate cas 3039-83-6: 75.01 %
Constituent 2 : Isethionate bisether, disodium salt cas 63440-92-6: 16.52%
Impurity 1:Isethionate sodium cas 1562-00-1:4.12%
Impurity 2:Sodium ethionate, disodium salt cas1562-03-4:0.62 %
Impurity 3:Sodium sulfate cas 7757-82-6 :2.76 %
Impurity 4:Sodium ethandisulfonate disodium salt cas 5325-43-9:0.64 % - Details on the study design:
- 1)Test systhem
Synthetic peptides containing cysteine (SPCC) (Ac RFAACAA COOH) or synthetic peptides containing lysine (SPCL) (Ac RFAAKAA COOH). The molecular weight is 750.9 g/mol for SPCC and 775.9 g/mol for SPCL.
Recommended test system in the international OECD guideline for DPRA studies.
JPT Peptide Technologies GmbH, Berlin, Germany.
batch cysteine 111016HS-MHeW0721
batch lysine :020517HS-MheW0721
The peptides were stored in the freezer set to maintain -20°C for a maximum of 6 months.
2)Vehicle/ Pos Control
vehicle used: MQ water
Positive control :cinnamaldehyde - Vehicle / solvent:
- water
- Positive control:
- cinnamic aldehyde
- Key result
- Group:
- test chemical
- Run / experiment:
- mean
- Parameter:
- other: Mean cysteine and lysine depletion
- Value:
- 1.5 %
- At concentration:
- 100 mM
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Cysteine 1:10 and Lysine 1:50 prediction model.
- Other effects / acceptance of results:
- The coefficient of determination (r2) of the SPCL standard calibration curve was 0.9992. As the r2 was >0.99, the SPCL standard calibration curve was accepted.
The mean peptide concentration of Reference Controls A was 0.496 ± 0.005 mM, the mean peptide concentration of Reference Controls C was 0.504 ± 0.004 mM and the mean peptide concentration of Reference Controls CMQ was 0.496 ± 0.007 mM. The means of Reference Control samples A, C and CMQ were all within the acceptance criteria of 0.50 ± 0.05 mM. This confirms the suitability of the HPLC system and indicates that the solvent (MQ) used to dissolve the test item did not impact the Percent SPCL Depletion.
The CV of the peptide areas for the nine Reference Controls B and C was 1.1%. This was within the acceptance criteria (CV <15.0%) and confirms the stability of the HPLC run over time.
The mean area ratio (A220/A258) of the Reference Control samples was 32.74. The mean A220/A258 ratio ± 10% range was 29.47-36.01. Each sample showing an A220/A258 ratio within this range gives an indication that co-elution has not occurred.
The Percent SPCL Depletion was calculated versus the mean SPCL peak area of Reference Controls C. The mean Percent SPCL Depletion for the positive control cinnamic aldehyde was 64.7% ± 0.7%. This was within the acceptance range of 40.2% to 69.0% with a SD that was below the maximum (SD <11.6%). - Conclusions:
- The mean of the SPCC and SPCL depletion was 1.5% and as a result the test item was negative in the DPRA and was classified in the “no or minimal reactivity class” when using the Cysteine 1:10 / Lysine 1:50 prediction model.
- Executive summary:
In conclusion, this DPRA test is valid. Reaction mass of disodium 2,2’-oxydiethanesulfonate and sodium ethenesulfonate was negative in the DPRA and was classified in the “no or minimal reactivity class” when using the Cysteine 1:10 / Lysine 1:50 prediction model.
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2021
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 luciferase KeratinoSens™ test method)
- GLP compliance:
- yes
- Type of study:
- ARE-Nrf2 luciferase KeratinoSens™ test method
- Specific details on test material used for the study:
- Reaction mass of disodium 2,2 oxydiethanesulfonate and sodium ethenesulfonate
Batch lot number:202108300033
Dry weight content : 33.65 % - Vehicle / solvent control:
- DMSO
- Positive control:
- other: Ethylene dimethacrylate glycol
- Positive control results:
- • The luciferase activity induction obtained with the positive control, Ethylene dimethacrylate glycol, was statistically significant above the threshold of 1.5-fold in at least one concentration.
• The EC1.5 of the positive control was within two standard deviations of the historical mean (72 µM and 67 µM in experiment 1 and 2, respectively). A dose response was observed and the induction at 250 µM was higher than 2-fold (2.19-fold and 2.84-fold in experiment 1 and 2, respectively). - Key result
- Run / experiment:
- run/experiment 2
- Parameter:
- Imax [442D]
- Value:
- 1.2 %
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Run / experiment:
- run/experiment 1
- Parameter:
- Imax [442D]
- Value:
- 1.18 %
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Outcome of the prediction model:
- negative [in vitro/in chemico]
- Other effects / acceptance of results:
- Both tests passed the acceptance criteria:
• The luciferase activity induction obtained with the positive control, Ethylene dimethacrylate glycol, was statistically significant above the threshold of 1.5-fold in at least one concentration.
• The EC1.5 of the positive control was within two standard deviations of the historical mean (72 µM and 67 µM in experiment 1 and 2, respectively). A dose response was observed and the induction at 250 µM was higher than 2-fold (2.19-fold and 2.84-fold in experiment 1 and 2, respectively).
• Finally, the average coefficient of variation of the luminescence reading for the vehicle (negative) control DMSO was below 20% (6.5% and 5.6% in experiment 1 and 2, respectively).
Overall it is concluded that the test conditions were adequate and that the test system functioned properly.
The test item showed no toxicity (no IC30 and IC50 value) and no biologically relevant induction of the luciferase activity (no EC1.5 value) was measured at any of the test concentrations in both experiments. The maximum luciferase activity induction (Imax) was 1.18-fold and 1.20-fold in experiment 1 and 2 respectively. The test item is classified as negative in the KeratinoSensTM assay since negative results (<1.5-fold induction) were observed at test concentrations up to 400 µg/mL. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item showed no toxicity (no IC30 and IC50 value) and no biologically relevant induction of the luciferase activity (no EC1.5 value) was measured at any of the test concentrations in both experiments. The maximum luciferase activity induction (Imax) was 1.18-fold and 1.20-fold in experiment 1 and 2 respectively. The test item is classified as negative in the KeratinoSensTM assay since negative results (<1.5-fold induction) were observed at test concentrations up to 400 µg/mL.
- Executive summary:
The objective of this study was to evaluate the ability of Reaction mass of disodium 2,2’-oxydiethanesulfonate and sodium ethenesulfonate to activate the antioxidant/electrophile responsive element (ARE)-dependent pathway in the KeratinoSensÔ assay.
The study procedures described in this report were based on the most recent OECD guideline.
Batch 202108300033 of the test item was a clear light-yellow liquid with a purity of 33.65%. A correction factor of 2.971 was used to correct for the purity (33.65%). The test item was dissolved in dimethyl sulfoxide (DMSO) at 40 mg/mL. From this stock 11 spike solutions in DMSO were prepared. The stock and spike solutions were diluted 100-fold in the assay resulting in test concentrations of 0.20 – 400 µg/mL (2-fold dilution series). The highest test concentration was the highest dose required in the current guideline. No precipitate was observed at any dose level tested. Two independent experiments were performed.
Both tests passed the acceptance criteria:
- The luciferase activity induction obtained with the positive control, Ethylene dimethacrylate glycol, was statistically significant above the threshold of 1.5-fold in at least one concentration.
- The EC5 of the positive control was within two standard deviations of the historical mean (72 µM and 67 µM in experiment 1 and 2, respectively). A dose response was observed and the induction at 250 µM was higher than 2-fold (2.19-fold and 2.84-fold in experiment 1 and 2, respectively).
- Finally, the average coefficient of variation of the luminescence reading for the vehicle (negative) control DMSO was below 20% (6.5% and 5.6% in experiment 1 and 2, respectively).
Overall it is concluded that the test conditions were adequate and that the test system functioned properly.
The test item showed no toxicity (no IC30 and IC50 value) and no biologically relevant induction of the luciferase activity (no EC1.5 value) was measured at any of the test concentrations in both experiments. The maximum luciferase activity induction (Imax) was 1.18-fold and 1.20-fold in experiment 1 and 2 respectively. The test item is classified as negative in the KeratinoSensTM assay since negative results (<1.5-fold induction) were observed at test concentrations up to 400 µg/mL.
In conclusion, Reaction mass of disodium 2,2’-oxydiethanesulfonate and sodium ethenesulfonate is classified as negative (no activation of the antioxidant/electrophile responsive element (ARE)-dependent pathway in keratinocytes) under the experimental conditions described in this report.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Justification for classification or non-classification
The results available from the three in vitro tests of the sensitisation AOP test battery reveal three negative results (USENS OECD 442E, KeratinoSens OECD 442D, and DPRA 442C). Based on these data, the test item does not meet the criteria for classification according to Regulation (EC) 1272/2008 and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.